GlobalData on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other ...
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation ...
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement ...
Currently, the MyoRegulator® device is under investigation as a non-invasive treatment for ALS in a second and larger clinical trial, the CALM ( C ontrolling A myotrophic L ateral Sclerosis M otor ...
Boston Scientific Corporation (NYSE:BSX) is included in our list of the best stocks to buy right now. On January 12, 2026, ...
Dubai, UAE – Fakeeh University Hospital (FUH) in collaboration with Verita Neuro announces the launch of the first epidural stimulation program in the Middle East, marking a transformative moment in ...
Background Spinal cord stimulation (SCS) has become a cornerstone of neuromodulatory interventions for chronic pain, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results